7
Total investments
3
Early stage
1
Mid stage
0
Late stage
12y
Years active
Portfolio
4 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Board Member
Jan 2019
New Culture is leading the global change to an animal-free dairy future. We’re revolutionizing how cheese is made by combining traditional cheesemaking methods with modern fermentation technology. Using our groundbreaking science, any cheese is possible and can be made completely animal-free.
First up is our craveable, sustainable, animal-free mozzarella that melts, stretches, bubbles, and browns to perfection. With a completely animal-free process, our cheese is free from lactose, cholesterol, hormones, and antibiotics and we cut down on water, land, energy usage by 5-10x. Not bad for a slice of pizza.
We believe our food choices can transform our food system and help heal the planet, one cheese at a time. The animal-free future of dairy is here—and it’s delicious.
Board Member
Aug 2018
Geltor is the biodesign company that audaciously imagines and deeply explores all the possibilities that the tree of life has to offer. With customer benefit at the fore of each step of the creative process, Geltor has created the largest selection of designer proteins that are crafted with unparalleled biocompatibility and functionality. These proteins are 100% animal- and GMO-free, globally scalable, and sustainably cultivated. Geltor’s products are the result of endless curiosity and ceaseless optimization, clinically demonstrated for high performance.
Board Member
2016
SyntheX uses synthetic biology to create the next generation of drug discovery platforms. Using genetically engineered circuits, we rely on intracellular drug selection as opposed to in-vitro screening. This allows us to discover unbiased compounds with novel modes of action that can engage targets in either competitive or allosteric ways. We have developed ToRPPIDO to discover disruptors of protein-protein interactions (PPIs), and ToRNeDO to discover functional molecular glues for degraders of a neosubstrate of interest with a desired E3 ligase.
In the same cells, we incorporate our proprietary DNA-encoded libraries of peptides and macrocycles to enable the production and selection of molecules in an efficient and high throughput manner.
Our lead programs focus on oncology.
Experience · 12 entries
All (12)
Investments (7)
Founder (3)
Board (7)
2020
Partner
Jul 2020
For more than 56 years, we’ve partnered with founders from their first idea through the long arc of building iconic companies. Our track record includes 120 IPOs and 225+ acquisitions, reflecting our belief that great companies are built by people first. Across multiple market cycles, our team brings deep investing and operating experience to support founders with conviction, long-term capital, and hands-on partnership. Headquartered in Silicon Valley, Mayfield backs founders building the future of AI. People First. From Inception. Learn more at mayfield.com.
2019
Board Member
Jan 2019
New Culture is leading the global change to an animal-free dairy future. We’re revolutionizing how cheese is made by combining traditional cheesemaking methods with modern fermentation technology. Using our groundbreaking science, any cheese is possible and can be made completely animal-free.
First up is our craveable, sustainable, animal-free mozzarella that melts, stretches, bubbles, and browns to perfection. With a completely animal-free process, our cheese is free from lactose, cholesterol, hormones, and antibiotics and we cut down on water, land, energy usage by 5-10x. Not bad for a slice of pizza.
We believe our food choices can transform our food system and help heal the planet, one cheese at a time. The animal-free future of dairy is here—and it’s delicious.
2018
Board Member
Aug 2018
Geltor is the biodesign company that audaciously imagines and deeply explores all the possibilities that the tree of life has to offer. With customer benefit at the fore of each step of the creative process, Geltor has created the largest selection of designer proteins that are crafted with unparalleled biocompatibility and functionality. These proteins are 100% animal- and GMO-free, globally scalable, and sustainably cultivated. Geltor’s products are the result of endless curiosity and ceaseless optimization, clinically demonstrated for high performance.
B
BioAesthetics
Board Observer
Jan 2018
2017
P
Prellis Biologics
Board Member
Oct 2017
Show all 12 entries ↓
Investment activity
2014–2019 · 7 investments
Recent (last 2 years)Earlier
Similar investors
Co-invested with Arvind
Investor lists
Lists that match Arvind's portfolio
- Biotechnology investors in United States2,527 investors
- Food and Beverage investors in United States2,477 investors
- Wellness investors in United States2,620 investors
- Startup investors in United States6,245 investors





